# Synaptic and intrinsic membrane defects disrupt early neural network dynamics in Down syndrome

**Authors:** Saad B. Hannan, Ivan Alić, Aoife Murray, Joonhong Kwon, Martin Mortensen, Hyo Jung Kang, Ante Plećaš, Pollyanna A. Goh, Niamh L. O’Brien, Richard Naud, Dean Nižetić, Trevor G. Smart

PMC · DOI: 10.1038/s41467-025-68048-x · Nature Communications · 2026-01-22

## TL;DR

This study shows that Down syndrome disrupts early brain cell activity through faulty connections and ion channels, leading to cognitive issues.

## Contribution

The study identifies specific synaptic and ion channel defects in Down syndrome neurons using isogenic human-derived models.

## Key findings

- Trisomy 21 causes impaired glutamatergic synaptic connectivity and altered K+ and Na+ channel activity.
- A-type K+ channels, specifically Kv4.3, are critical in Down syndrome neurodevelopmental defects.
- These defects disrupt neural network activity and neuron synchrony during development.

## Abstract

Down syndrome, caused by trisomy 21, affects around six million people worldwide and features learning, memory and language deficits. However, the mechanisms underlying trisomy 21 neurophenotypes involving human cortical circuitry are unknown. By characterising developing neural network dynamics and single cell excitability profiles, from synaptic and voltage-dependent ion channel behaviour using an isogenic induced pluripotent stem cell-derived neuronal model, we show that trisomy 21 impairs the activity and development of cortical circuitry. This is caused by deficient glutamatergic synaptic connectivity and by aberrant intrinsic membrane properties involving K+ and Na+ channels culminating in spike firing defects that weaken neural network activity and disrupt the synchrony of developing neurons. We also identify transiently activated A-type K+ channels, specifically Kv4.3 channels, as a key orchestrator for Down syndrome during neurodevelopment. Overall, these excitability changes will significantly contribute towards the aberrant neurophenotypes observed later on in life.

Down syndrome (DS) increases gene dosage that disrupts neurodevelopment and cognition. Using human-derived isogenic neurons, this study reveals altered network activity, synaptic dysfunction, and ion channel defects underlying DS neural impairment.

## Linked entities

- **Proteins:** KCND3 (potassium voltage-gated channel subfamily D member 3)
- **Diseases:** Down syndrome (MONDO:0008608)

## Full-text entities

- **Genes:** Syn1 (synapsin I) [NCBI Gene 20964] {aka Syn-1, Syn1-S}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Kcnd2 (potassium voltage-gated channel, Shal-related family, member 2) [NCBI Gene 16508] {aka Gm52855, Kv4.2}, KCND2 (potassium voltage-gated channel subfamily D member 2) [NCBI Gene 491424], KCNC4 (potassium voltage-gated channel subfamily C member 4) [NCBI Gene 3749] {aka C1orf30, HKSHIIIC, KSHIIIC, KV3.4}, IFNAR2 (interferon alpha and beta receptor subunit 2) [NCBI Gene 3455] {aka IFN-R, IFN-R-2, IFN-alpha-REC, IFNABR, IFNARB, IMD45}, TRPM2 (transient receptor potential cation channel subfamily M member 2) [NCBI Gene 7226] {aka EREG1, KNP3, LTRPC2, LTrpC-2, NUDT9H, NUDT9L1}, Slc17a7 (solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7) [NCBI Gene 72961] {aka 2900052E22Rik, Vglut1}, GRIK1 (glutamate ionotropic receptor kainate type subunit 1) [NCBI Gene 2897] {aka EAA3, EEA3, GLR5, GLUR5, GluK1, gluR-5}, Kcnd3 (potassium voltage-gated channel, Shal-related family, member 3) [NCBI Gene 56543] {aka Kncd3, Kv4.3}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 13385] {aka Dlgh4, PSD-95, PSD95, SAP90, SAP90A}, MALAT1 (metastasis associated lung adenocarcinoma transcript 1) [NCBI Gene 378938] {aka HCN, LINC00047, NCRNA00047, NEAT2, PRO2853, miPEP-52}, MAP2 (microtubule associated protein 2) [NCBI Gene 488504], Tubb3 (tubulin, beta 3 class III) [NCBI Gene 22152] {aka 3200002H15Rik, M(beta)3, M(beta)6}, KCND2 (potassium voltage-gated channel subfamily D member 2) [NCBI Gene 3751] {aka KV4.2, RK5}, IL10RB (interleukin 10 receptor subunit beta) [NCBI Gene 3588] {aka CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IBD25}, Pax6 (paired box 6) [NCBI Gene 18508] {aka 1500038E17Rik, AEY11, Dey, Gsfaey11, Pax-6, Sey}, KCNA4 (potassium voltage-gated channel subfamily A member 4) [NCBI Gene 3739] {aka HBK4, HK1, HPCN2, HUKII, KCNA4L, KCNA8}, Map2 (microtubule-associated protein 2) [NCBI Gene 17756] {aka G1-397-34, MAP-2, Mtap-2, Mtap2, repro4}, Sox2 (SRY (sex determining region Y)-box 2) [NCBI Gene 20674] {aka Sox-2, lcc, ysb}, KCND3 (potassium voltage-gated channel subfamily D member 3) [NCBI Gene 3752] {aka BRGDA9, KCND3L, KCND3S, KSHIVB, KV4.3, SCA19}, KCND3 (potassium voltage-gated channel subfamily D member 3) [NCBI Gene 403758], Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], IFNGR2 (interferon gamma receptor 2) [NCBI Gene 3460] {aka AF-1, IFGR2, IFNGT1, IMD28}, KCNJ6 (potassium inwardly rectifying channel subfamily J member 6) [NCBI Gene 3763] {aka BIR1, GIRK-2, GIRK2, KATP-2, KATP2, KCNJ7}, KCNC3 (potassium voltage-gated channel subfamily C member 3) [NCBI Gene 3748] {aka KSHIIID, KV3.3, SCA13}, Nes (nestin) [NCBI Gene 18008] {aka ESTM46, Ifaprc2, Marc2, RC2}, SYN1 (synapsin I) [NCBI Gene 100685486] {aka Synapsin-1}, Gdnf (glial cell line derived neurotrophic factor) [NCBI Gene 14573] {aka ATF}
- **Diseases:** type K+ channel (MESH:D014813), trisomy (MESH:D014314), synaptic deficits (MESH:D009461), cognitive impairment (MESH:D003072), ataxia (MESH:D001259), learning, memory and language deficits (MESH:D007859), A-current defects (MESH:D000013), intellectual disability (MESH:D008607), EPSCs (MESH:D020294), cardiac defects (MESH:D006331), neurodevelopmental defects (MESH:D065886), Voltage-gated Na+ channel inactivation (MESH:C572568), type (MESH:D006969), DS (MESH:D004314), psychiatric (MESH:D001523), neurological and neurodegenerative conditions (MESH:D019636), DFC (MESH:D014854), neurotoxic (MESH:D020258), neural impairment (MESH:D015441)
- **Chemicals:** CaCl2 (MESH:D002122), K (MESH:D011188), streptomycin (MESH:D013307), penicillin (MESH:D010406), Mg-ATP (MESH:D000255), bicuculline (MESH:D001640), TTX (MESH:D013779), CNQX (MESH:D018750), EGTA (MESH:D004533), AMPA (MESH:D018350), GABA (MESH:D005680), CsCl (MESH:C028019), KCl (MESH:D011189), QX314 (MESH:C012647), NaCl (MESH:D012965), Bis-Tris (MESH:C026272), oil (MESH:D009821), Alexa Fluor 555 (MESH:C000608607), HEPES (MESH:D006531), CdCl2 (MESH:D019256), APV (MESH:C095108), glutamate (MESH:D018698), Alexa Fluor 488 (MESH:C000711379), poly-L-ornithine (MESH:C008973), AP (MESH:D000667), NMDA (MESH:D016202), A- (MESH:D001151), BaCl2 (MESH:C024986), AM (MESH:D000576), DAPI (MESH:C007293), KOH (MESH:C029943), glucose (MESH:D005947), MgCl2 (MESH:D015636), Na (MESH:D012964), DPBS (-), TEA (MESH:D019789), 4-AP (MESH:D015761), BAPTA (MESH:C025603), ascorbic acid (MESH:D001205), Alexa Fluor 647 (MESH:C569686)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Mycoplasma (genus) [taxon 2093], Gallus gallus (bantam, species) [taxon 9031]
- **Cell lines:** L2020-1MG — Homo sapiens (Human), Lung small cell carcinoma, Cancer cell line (CVCL_D076), T21 — Homo sapiens (Human), Down syndrome, Induced pluripotent stem cell (CVCL_1E83), D21 — Canis lupus familiaris (Dog), Canine osteosarcoma, Cancer cell line (CVCL_S349)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12868644/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12868644/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12868644/full.md

---
Source: https://tomesphere.com/paper/PMC12868644